Relationship between [125I]RTI-55-labeled cocaine binding sites and the serotonin transporter in rat placenta

American Journal of Physiology - Cell Physiology

Volumn 275, Issue 6 44-6, 1998, Pages

  Shearman, Lauren P ^a,c   McReynolds, Alison M ^a   Zhou, Feng C ^b   Meyer, Jerrold S ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b INDIANA UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Development; Immunocytochemistry; Paroxetine; Uptake

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CITALOPRAM; CLOMIPRAMINE; COCAINE; NISOXETINE; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; CARRIER PROTEIN; DRUG DERIVATIVE; MEMBRANE PROTEIN; NERVE PROTEIN; RADIOACTIVE IODINE; SLC6A4 PROTEIN, RAT;

ANIMAL TISSUE; ARTICLE; BINDING SITE; COCAINE DEPENDENCE; CONTROLLED STUDY; FETUS DEVELOPMENT; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; ANIMAL; AUTORADIOGRAPHY; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALIA;

ANIMALS; AUTORADIOGRAPHY; BINDING SITES; CARRIER PROTEINS; COCAINE; FEMALE; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PAROXETINE; PLACENTA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TISSUE DISTRIBUTION;

EID: 0032433926     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1998.275.6.c1621     Document Type: Article

References (20)

1. Ahmed, M. S., D.-H. Zhou, D. Maulik, and M. E. Eldefrawi. Characterization of a cocaine binding protein in human placenta. Life Sci. 46: 553-561, 1990.
2. Altshuler, L. L., L. Cohen, M. P. Szuba, V. K. Burt, M. Gitlin, and J. Mintz. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am. J. Psychiatry 153: 592-606, 1996.
3. Barker, E. L., H. L. Kimmel, and R. D. Blakely. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol. Pharmacol. 46: 799-807, 1994.
4. Bengel, D., D. L. Murphy, A. M. Andrews, C. H. Wichems, D. Feltner, A. Heils, R. Mössner, H. Westphal, and K.-P. Lesch. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol. Pharmacol. 53: 649-655, 1998.
5. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12: 27-36, 1992.
6. Bradford, M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
7. Branchek, T. A., and M. D. Gershon. Time course of expression of neuropeptide Y, calcitonin gene-related peptide, and NADPH diaphorase activity in neurons of the developing murine bowel and the appearance of 5-hydroxytryptamine in mucosal enterochromaffin cells. J. Comp. Neurol. 285: 262-283, 1989.
8. Bzoskie, L., L. Blount, K. Kashiwai, Y.-T. Tseng, W. W. Hay, Jr., and J. F. Padbury. Placental norepinephrine clearance: in vivo measurement and physiological role. Am. J. Physiol. 269 (Endocrinol. Metab. 32): E145-E149, 1995.
9. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membr. Biochem. 7: 87-106, 1988.
10. Chambers, C. D., K. A. Johnson, L. M. Dick, R. J. Felix, and K. L. Jones. Birth outcomes in pregnant women taking fluoxetine. N. Engl. J. Med. 335: 1010-1015, 1996.
11. Chen, C. H., D. C. Klein, and J. C. Robinson. Monoamine oxidase in rat placenta, human placenta, and cultured choriocarcinoma. J. Reprod. Fertil. 46: 477-479, 1976.
12. Cool, D. R., F. H. Leibach, and V. Ganapathy. High-affinity paroxetine binding to the human placental serotonin transporter. Am. J. Physiol. 259 (Cell Physiol. 28): C196-C204, 1990.
13. Essman, W. B., and B. E. Cooper. Serotonin and early development. In: Serotonin in Health and Disease. Vol. II, Physiological Regulation and Pharmacological Action, edited by W. B. Essman. New York: Spectrum, 1978, p. 69-157.
14. Fox, S. B., and T. Y. Khong. Lack of innervation of human umbilical cord. An immunohistological and histochemical study. Placenta 11: 59-62, 1990.
15. Ganapathy, V., S. Ramamoorthy, and F. H. Leibach. Transport and metabolism of monoamines in the human placenta. Trophoblast Res. 7: 35-51, 1993.
16. Gonzalez, C., M. A. Cruz, W. H. Sepulveda, and M. I. Rudolph. Effects of serotonin on vascular tone of isolated human placental chorionic veins. Gynecol. Obstet. Invest. 29: 88-91, 1990.
17. Gu, H., S. C. Wall, and G. Rudnick. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269: 7124-7130, 1994.
18. Hansson, S. R., É. Mezey, and B. J. Hoffman. Serotonin transporter mRNA localization in the developing rat embryo (Abstract). Soc. Neurosci. Abstr. 21: 865, 1995.
19. Hourani, S. M., and N. J. Cusack. Pharmacological receptors on blood platelets. Pharmacol. Rev. 43: 243-285, 1991.
20. 125I]RTI-55. Synapse 12: 99-111, 1992.